133 related articles for article (PubMed ID: 34929472)
1. Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tisue sarcoma Study Group recommendations.
Enault M; Minard-Colin V; Corradini N; Leverger G; Thebaud E; Rome A; Proust S; Marie-Cardine A; Defachelles AS; Sarnacki S; Philippe-Chomette P; Delattre O; Masliah-Planchon J; Lacour B; Ferrari A; Brennan B; Orbach D; Bourdeaut F
Eur J Cancer; 2022 Jan; 161():64-78. PubMed ID: 34929472
[TBL] [Abstract][Full Text] [Related]
2. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
[TBL] [Abstract][Full Text] [Related]
3. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic risk factors define two risk groups of extracranial malignant rhabdoid tumours (eMRT/RTK).
Nemes K; Bens S; Kachanov D; Teleshova M; Hauser P; Simon T; Tippelt S; Woessmann W; Beck O; Flotho C; Grigull L; Driever PH; Schlegel PG; Khurana C; Hering K; Kolb R; Leipold A; Abbink F; Gil-Da-Costa MJ; Benesch M; Kerl K; Lowis S; Marques CH; Graf N; Nysom K; Vokuhl C; Melchior P; Kröncke T; Schneppenheim R; Kordes U; Gerss J; Siebert R; Furtwängler R; Frühwald MC
Eur J Cancer; 2021 Jan; 142():112-122. PubMed ID: 33249395
[TBL] [Abstract][Full Text] [Related]
5. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience.
Orbach D; Brennan B; De Paoli A; Gallego S; Mudry P; Francotte N; van Noesel M; Kelsey A; Alaggio R; Ranchère D; De Salvo GL; Casanova M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Ferrari A
Eur J Cancer; 2016 Apr; 57():1-9. PubMed ID: 26849118
[TBL] [Abstract][Full Text] [Related]
6. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Prognostic Characteristics of 53 Cases of Extracranial Malignant Rhabdoid Tumor in Children. A Single-Institute Experience from 2007 to 2017.
Cheng H; Yang S; Cai S; Ma X; Qin H; Zhang W; Fu L; Zeng Q; Wen M; Peng X; Wang H
Oncologist; 2019 Jul; 24(7):e551-e558. PubMed ID: 30914466
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
Yamamoto M; Suzuki N; Hatakeyama N; Mizue N; Hori T; Kuroiwa Y; Hareyama M; Oda T; Kudoh T; Nui A; Matsuno T; Hirama T; Yokoyama S; Dome JS; Tsutsumi H
J Pediatr Hematol Oncol; 2006 May; 28(5):286-9. PubMed ID: 16772877
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
11. Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
Bergeron C; Jenney M; De Corti F; Gallego S; Merks H; Glosli H; Ferrari A; Ranchère-Vince D; De Salvo GL; Zanetti I; Chisholm J; Minard-Colin V; Rogers T; Bisogno G;
Eur J Cancer; 2021 Mar; 146():21-29. PubMed ID: 33567392
[TBL] [Abstract][Full Text] [Related]
12. Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study.
Ferrari A; Chisholm JC; Jenney M; Minard-Colin V; Orbach D; Casanova M; Guillen G; Glosli H; van Rijn RR; Schoot RA; Cameron AL; Rogers T; Alaggio R; Ben-Arush M; Mandeville HC; Devalck C; Defachelles AS; Coppadoro B; Bisogno G; Merks JHM
Lancet Child Adolesc Health; 2022 Aug; 6(8):545-554. PubMed ID: 35690071
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
Lu E; Ryan CW; Bassale S; Lim JY; Davis LE
Oncologist; 2020 Feb; 25(2):150-155. PubMed ID: 32043790
[TBL] [Abstract][Full Text] [Related]
16. Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Felgenhauer J; Hawkins D; Pendergrass T; Lindsley K; Conrad EU; Miser JS
Med Pediatr Oncol; 2000 Jan; 34(1):29-38. PubMed ID: 10611582
[TBL] [Abstract][Full Text] [Related]
17. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
18. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children.
Venkatramani R; Shoureshi P; Malvar J; Zhou S; Mascarenhas L
Pediatr Blood Cancer; 2014 Aug; 61(8):1357-61. PubMed ID: 24789740
[TBL] [Abstract][Full Text] [Related]
19. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy for brain tumors in infants and young children.
Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
